Stress and interferon signaling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1 (read more) Background Although NGLY1 is known as a pivotal enzyme that catalyses the deglycosylation of...
Read More
Download our "About NGLY1 Deficiency" handbook today at https://www.ngly1.org/handbook. This comprehensive booklet includes information on: * Symptoms * Diagnosis * Prognosis * Medical Patient Care * Therapies ... and...
Read More
Recently published on Pubmed. Mitochondrial respiratory chain (RC) diseases and congenital disorders of glycosylation (CDG) share extensive clinical overlap but are considered to have distinct cellular pathophysiology. Here, we demonstrate...
Read More
Join the Mark2CureAThon on May 11/12 to search for clues on a rare disease by identifying genes, diseases, drugs, and the relationships between these based on literature surrounding the NGLY1. ...
Read More
Researchers from the RIKEN Global Research Cluster in Japan have developed a potential mouse model for the genetic disorder known as an NGLY1 deficiency. Published in the journal PLOS Genetics,...
Read More
Mitali Tambe, Ph.D., from the Hudson Freeze Lab at Sanford Burnham Prebys Research Institute presented on NGLY1 for the ASBMB’s Art of Science Communication.
Recent research in the NGLY1 community has been published on Nature.com. To read the entire journal article called “JOURNAL ARTICLE: Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation”,…
Recent Comments